Abstract

Abstract Six new triorganotin(iv) complexes of 3-aminobenzoic acid-based Schiff bases, 3-(R′-CH═N)C6H4COOSnR3 (1–6) (R′, R = 5-Br-2-HOC6H3, Ph (1); 3,5-Br2-2-HOC6H2, Ph (2); 4-NEt2-2-HOC6H3, Cy (3); 3-OCH3-2-HOC6H3, Cy (4); 2-HOC10H6, Ph (5); 2-HOC10H6, Cy (6)), have been synthesized by the one-pot reaction of equimolar 3-aminobenzoic acid, substituted 2-hydroxybenzaldehyde (or 2-hydroxy-1-naphthaldehyde) and triorganotin(iv) hydroxide, and characterized by elemental analysis, FT-IR, NMR spectroscopy, and X-ray single crystal diffraction. The NMR data (1 J(119Sn–13C) and 119Sn chemical shifts) suggested that these organotin(iv) complexes are all four-coordinated in CDCl3 solution. In the crystalline state, the tin atoms in 1–4 and 6 are four-coordinated and possess a distorted tetrahedral geometry. Complex 5 with crystalline solvents (CH3OH and CHCl3) exhibits a zigzag chain, and the five coordination atoms on the tin atom are arranged in a trigonal bipyramidal geometry in which the carboxylate oxygen atom and the phenolic oxygen atom of the adjacent ligand occupy the axial positions. In all complexes, the 3-(arylmethyleneamino)benzoate ligands are coordinated with tin atoms in monodentate mode. Their cytotoxicity against two human cancer cell lines (A549 and HeLa), UV-Vis, and fluorescence have been determined, and the results reveal that complexes 1–6 have higher cytotoxicity than cisplatin and may be explored for potential blue luminescent materials.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.